The New Drill: How Private Equity is Reshaping Dentistry, One Practice at a Time

NASHVILLE, TN – June 16, 2026 – On the surface, the announcement was standard corporate fare: Innovate 32, a burgeoning dental services organization (DSO), revealed its partnership with Viridian Dental Partners, a respected network of five practices across Middle Tennessee. For the communities of Nashville, Dickson, Goodlettsville, Antioch, and Franklin, it means the local dental office has a new backer. But beneath the press-release polish lies a far more significant story—a microcosm of the tectonic shift transforming American healthcare, where private equity’s financial engineering is meeting the intimate, trust-based world of patient care.

Innovate 32, itself a Nashville-based entity, is rapidly expanding its footprint throughout the South and Mid-Atlantic. The partnership with Viridian, which brings eight doctors and their established patient bases into the fold, is described as a pivotal step. “Viridian Dental Partners has built an impressive practice with a strong culture, dedicated providers, and an unwavering commitment to patient care,” said Josh Johnson, CEO of Innovate 32, in the official statement. “We are proud to welcome [them] to the Innovate 32 family.”

This is not merely a regional firm buying another. Innovate 32 is a platform company launched in July 2024 by Shore Capital, a Chicago-based private equity firm managing over $9 billion in assets. This partnership isn't just about dentistry; it's about executing a well-funded, meticulously planned investment thesis.

The Consolidation Playbook

The dental industry, long characterized by fragmented, independent solo practices, has become a prime target for private equity’s “buy-and-build” strategy. DSOs like Innovate 32 offer a solution to the administrative burdens that often bog down clinicians—handling everything from payroll and marketing to procurement and compliance. This allows dentists, in theory, to focus solely on their craft.

The numbers bear out the trend. Industry data shows that over 16% of U.S. dentists are now affiliated with a DSO, a figure that has climbed steadily as solo practices decline. For early-career dentists graduating with significant debt, the appeal of a DSO offering a guaranteed salary, benefits, and student loan assistance is often irresistible, making it harder for independent practices to compete for talent.

Shore Capital is a seasoned player in this arena. Before launching Innovate 32, the firm had already built and scaled other healthcare platforms, including Great Lakes Dental Partners and Southern Orthodontic Partners. Their model is clear: identify a fragmented market, partner with a strong local operator to create a platform, and then use that platform to acquire smaller “add-on” practices, creating regional density and operational efficiencies. Innovate 32’s rapid expansion since its founding—with acquisitions not just in Tennessee but also in Texas and Florida—demonstrates the aggressive pace of this strategy.

The financial mechanics are compelling. Advisory firms specializing in these transactions, like 7Pillars Advisory which represented Viridian, note that valuations are based on a multiple of EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization). While a single practice might sell for 5 to 8 times its earnings, a larger, integrated platform like the one Innovate 32 is building can command multiples of 8 to 12 times or more, creating significant value for its private equity backers.

Balancing Business and the Bedside Manner

The central promise of this model, and the one echoed by all parties in the Innovate 32 deal, is the preservation of clinical autonomy within a corporate structure. “Innovate 32’s commitment to supporting clinician-led organizations and preserving strong local cultures made them the right long-term partner,” said Alix Laurain, CEO of Viridian Dental Partners. Dr. James Fleming of Dentistry of Nashville, one of the acquired practices, added that the partnership “positions our teams to continue delivering outstanding clinical care.”

This is the delicate balance DSOs must strike. The model’s success hinges on convincing both dentists and patients that the pursuit of operational efficiency and shareholder returns will not compromise the quality of care. The risk is that the focus on key performance indicators (KPIs) and optimized scheduling could erode the patient-centric culture that made these local practices successful in the first place.

Furthermore, the industry is grappling with significant staffing shortages, particularly for dental hygienists. An analysis from the ADA Health Policy Institute indicates that nearly 40% of practices are struggling to find adequate hygiene staff. With their centralized resources and deep capital reserves, large DSOs are often better equipped to offer competitive compensation and benefits, giving them a powerful advantage in the war for talent. While this strengthens the DSO, it can further squeeze the remaining independent practices, accelerating the very consolidation trend that fuels their growth.

The Patient Impact in Middle Tennessee

For the thousands of patients served by Dentistry of Nashville, East Hills Dental Center, and the other Viridian practices, the long-term effects of this partnership remain to be seen. The infusion of capital from Innovate 32 and Shore Capital could lead to tangible benefits, such as upgraded facilities, access to cutting-edge dental technology, and more streamlined digital services for booking and communication.

However, consolidation often brings changes that are less visible but deeply felt. Patients may face shifts in accepted insurance plans, adjustments to service pricing, or a change in the familiar front-office staff. The very identity of a practice like Dentistry of Nashville, which previously prided itself on being a “small, independently-owned practice,” is now part of a much larger, financially-driven network.

The transaction, advised by Brian Christensen of 7Pillars Advisory, is a strategic move in a market where scale is becoming synonymous with survival. But as more of these deals are inked, the fundamental question for patients in Middle Tennessee and across the country remains: can a model designed to maximize financial returns for investors also deliver the best possible health outcomes for the community? The Innovate 32-Viridian partnership will now become a real-world test case, watched closely by patients, practitioners, and investors alike.